QR Code

Immune Checkpoint Inhibitors in Patients With Cancer and Infection by Hepatitis B or C Virus: A Perspective Through the Results of a European Survey

Introduction: Patients with cancer and hepatitis B virus (HBV) or hepatitis C virus (HCV) infection are underrepresented in several clinical trials testing immune checkpoint inhibitors (ICIs). Consequently, safety and efficacy of ICI therapy in this population have not been completely defined. We ai...

Whakaahuatanga katoa

I tiakina i:
Ngā kaituhi matua: Marco Tagliamento, MD, Jordi Remon, MD, PhD, Matteo Giaj Levra, MD, Andrea De Maria, MD, Paolo Bironzo, MD, PhD, Benjamin Besse, MD, PhD, Silvia Novello, MD, PhD, Laura Mezquita, MD, PhD
Hōputu: Artigo
Reo:Inglês
I whakaputaina: Elsevier 2023-01-01
Rangatū:JTO Clinical and Research Reports
Ngā marau:
Immune checkpoint inhibitors
Cancer
HBV
HCV
Immunotherapy
Viral hepatitis
Urunga tuihono:http://www.sciencedirect.com/science/article/pii/S2666364322001709
Ngā Tūtohu: Tāpirihia he Tūtohu
Kāore He Tūtohu, Me noho koe te mea tuatahi ki te tūtohu i tēnei pūkete!

Ngā tūemi rite